Medicalgorithmics Invests in Dynamic Growth in Clinical Research Sector
The rapidly increasing demand from the biopharmaceutical industry for services ensuring the cardiac safety of clinical drug trials represents a strong new trend in the global medical technology market. Medicalgorithmics, a medtech company listed on the sWIG80 index, intends to benefit from this trend by focusing on the development of high-margin services in this area. Last year, the company joined two international research projects and is now close to finalizing additional agreements and plans to collaborate with entities organizing clinical trials.